249 related articles for article (PubMed ID: 24593744)
21. Radiomics-based Assessment of Radiation-induced Lung Injury After Stereotactic Body Radiotherapy.
Moran A; Daly ME; Yip SSF; Yamamoto T
Clin Lung Cancer; 2017 Nov; 18(6):e425-e431. PubMed ID: 28623121
[TBL] [Abstract][Full Text] [Related]
22. Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
Pyka T; Bundschuh RA; Andratschke N; Mayer B; Specht HM; Papp L; Zsótér N; Essler M
Radiat Oncol; 2015 Apr; 10():100. PubMed ID: 25900186
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
[TBL] [Abstract][Full Text] [Related]
24. Computed Tomography Assessment of Ablation Zone Enhancement in Patients With Early-Stage Lung Cancer After Stereotactic Ablative Radiotherapy.
Moore W; Chaya Y; Chaudhry A; Depasquale B; Glass S; Lee S; Shin J; Mikhail G; Bhattacharji P; Kim B; Bilfinger T
J Comput Assist Tomogr; 2015; 39(5):804-9. PubMed ID: 25974720
[TBL] [Abstract][Full Text] [Related]
25. Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors.
Binkley MS; Shrager JB; Chaudhuri A; Popat R; Maxim PG; Shultz DB; Diehn M; Loo BW
Radiat Oncol; 2016 Mar; 11():40. PubMed ID: 26975700
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung.
Binkley MS; King MT; Shrager JB; Bush K; Chaudhuri AA; Popat R; Gensheimer MF; Maxim PG; Henry Guo H; Diehn M; Nair VS; Loo BW
Radiother Oncol; 2017 May; 123(2):270-275. PubMed ID: 28460826
[TBL] [Abstract][Full Text] [Related]
27. Long-term clinical experience of high-dose ablative lung radiotherapy: high pre-treatment [18F]fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome.
Lee DS; Kim YS; Yoo IeR; Kang YN; Kim SJ; Oh JK; Kim YK; Wang YP; Park JG; Kang JH; Han DH; Ahn MI; Lee KY
Lung Cancer; 2013 May; 80(2):172-8. PubMed ID: 23489556
[TBL] [Abstract][Full Text] [Related]
28. What is the predictive value of RECIST criteria following stereotactic lung radiation?
Gulstene S; Lang P; Melody Qu X; Laba JM; Yaremko BP; Rodrigues GB; Yu E; Qiabi M; Nayak R; Malthaner RA; Fortin D; Warner A; Inculet RI; Palma DA
Radiother Oncol; 2024 Jan; 190():109976. PubMed ID: 37918636
[TBL] [Abstract][Full Text] [Related]
29. Radiomic analysis for early differentiation of lung cancer recurrence from fibrosis in patients treated with lung stereotactic ablative radiotherapy.
Kunkyab T; Mou B; Jirasek A; Haston C; Andrews J; Thomas S; Hyde D
Phys Med Biol; 2023 Aug; 68(16):. PubMed ID: 37164024
[No Abstract] [Full Text] [Related]
30. Lung texture in serial thoracic computed tomography scans: correlation of radiomics-based features with radiation therapy dose and radiation pneumonitis development.
Cunliffe A; Armato SG; Castillo R; Pham N; Guerrero T; Al-Hallaq HA
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1048-56. PubMed ID: 25670540
[TBL] [Abstract][Full Text] [Related]
31. Patterns of Disease Recurrence after SABR for Early Stage Non-Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy.
Verstegen NE; Lagerwaard FJ; Hashemi SM; Dahele M; Slotman BJ; Senan S
J Thorac Oncol; 2015 Aug; 10(8):1195-200. PubMed ID: 26200274
[TBL] [Abstract][Full Text] [Related]
32. Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis.
Sanuki N; Takeda A; Mizuno T; Oku Y; Eriguchi T; Iwabuchi S; Kunieda E
AJR Am J Roentgenol; 2013 Dec; 201(6):W812-20. PubMed ID: 24261388
[TBL] [Abstract][Full Text] [Related]
33. Brief Report on Radiological Changes following Stereotactic Ablative Radiotherapy (SABR) for Early-Stage Lung Tumors: A Pictorial Essay.
Ronden MI; Palma D; Slotman BJ; Senan S;
J Thorac Oncol; 2018 Jun; 13(6):855-862. PubMed ID: 29518554
[TBL] [Abstract][Full Text] [Related]
34. Late radiologic changes after stereotactic ablative radiotherapy for early stage lung cancer: a comparison of fixed-beam versus arc delivery techniques.
Senthi S; Dahele M; van de Ven PM; Slotman BJ; Senan S
Radiother Oncol; 2013 Oct; 109(1):77-81. PubMed ID: 24060174
[TBL] [Abstract][Full Text] [Related]
35. A Systematic Review Into the Radiologic Features Predicting Local Recurrence After Stereotactic Ablative Body Radiotherapy (SABR) in Patients With Non-Small Cell Lung Cancer (NSCLC).
Lee K; Le T; Hau E; Hanna GG; Gee H; Vinod S; Dammak S; Palma D; Ong A; Yeghiaian-Alvandi R; Buck J; Lim R
Int J Radiat Oncol Biol Phys; 2022 May; 113(1):40-59. PubMed ID: 34879247
[TBL] [Abstract][Full Text] [Related]
36. Forecasting the impact of stereotactic ablative radiotherapy for early-stage lung cancer on the thoracic surgery workforce.
Edwards JP; Datta I; Hunt JD; Stefan K; Ball CG; Dixon E; Grondin SC
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1599-606. PubMed ID: 26796110
[TBL] [Abstract][Full Text] [Related]
37. Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer.
Yamamoto T; Kadoya N; Morishita Y; Sato Y; Matsushita H; Umezawa R; Ishikawa Y; Takahashi N; Katagiri Y; Takeda K; Jingu K
PLoS One; 2018; 13(10):e0204734. PubMed ID: 30286105
[TBL] [Abstract][Full Text] [Related]
38. CT Findings and Treatment Outcomes of Ground-Glass Opacity Predominant Lung Cancer After Stereotactic Body Radiotherapy.
Mikami N; Takeda A; Hashimoto A; Takeda T; Kimura Y; Oku Y; Aoki Y; Eriguchi T; Tsurugai Y; Saeki N; Enomoto T; Kuribayashi H; Masuda M; Kaneko T
Clin Lung Cancer; 2022 Jul; 23(5):428-437. PubMed ID: 35637134
[TBL] [Abstract][Full Text] [Related]
39. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study.
Ferrero C; Badellino S; Filippi AR; Focaraccio L; Giaj Levra M; Levis M; Moretto F; Torchio R; Ricardi U; Novello S
Lung Cancer; 2015 Sep; 89(3):350-6. PubMed ID: 26164208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
